Paid Clinical Trials Birmingham
Discover 601 paid clinical trials in Birmingham, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
LumateperoneMulticenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
Sponsor:
Intra-Cellular Therapies, Inc.
Location:
Code:
NCT06372964
Conditions
Bipolar Depression
Eligibility Criteria
Sex: All
Age: 10 - 17
Healthy Volunteers: Not accepted
Interventions
Lumateperone
Placebo
Investigational CMV Vaccine Study for Volunteers Ages 9–15Investigational CMV Vaccine Study for Volunteers Ages 9–15
Sponsor:
Moderna
Location:
Code:
NCT05575492
Conditions
Cytomegalovirus
Eligibility Criteria
Sex: All
Age: 9 - 15
Healthy Volunteers: Accepted
Interventions
mRNA-1647
Placebo
Acceptance and Commitment Therapy for Depressed People With Spinal Cord InjuriesAcceptance and Commitment Therapy for Depressed People With Spinal Cord Injuries
Sponsor:
University of Alabama at Birmingham
Location:
Code:
NCT06233656
Conditions
Depression
Spinal Cord Injuries
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Acceptance and commitment therapy (ACT)
Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE)Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE)
Sponsor:
University of North Carolina, Chapel Hill
Location:
Code:
NCT03554356
Conditions
Barrett Esophagus
Intestinal Metaplasia
Esophageal Dysplasia
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
CryoBalloon Focal Ablation System
A Community Health Worker Intervention to Address Adverse Pregnancy OutcomesA Community Health Worker Intervention to Address Adverse Pregnancy Outcomes
Sponsor:
University of Alabama at Birmingham
Location:
Code:
NCT06353256
Conditions
Preeclampsia Postpartum
Adverse Pregnancy Outcomes
Eligibility Criteria
Sex: Female
Age: 16 - 56
Healthy Volunteers: Accepted
Interventions
usual postpartum care
usual postpartum care + community health worker intervention
Alisertib & Endocrine TherapyA Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Sponsor:
Puma Biotechnology, Inc.
Location:
Code:
NCT06369285
Conditions
Hormone Receptor Positive HER-2 Negative Breast Cancer
Metastatic Breast Cancer
Recurrent Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Alisertib
Endocrine therapy
RESTORERESTORE: REducing Future FractureS and Improving OuTcOmes of FRagility FracturE
Sponsor:
University of Alabama at Birmingham
Location:
Code:
NCT06455085
Conditions
Osteoporosis
Osteoporotic Fractures
Eligibility Criteria
Sex: All
Age: 50+
Healthy Volunteers: Not accepted
Interventions
Augmented-Fracture Liaison Service Arm
Enhanced Usual Care Arm
BLU-263(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
Sponsor:
Blueprint Medicines Corporation
Location:
Code:
NCT04910685
Conditions
Indolent Systemic Mastocytosis
Monoclonal Mast Cell Activation Syndrome
Smoldering Systemic Mastocytosis
Eligibility Criteria
Sex: All
Age: 16+
Healthy Volunteers: Not accepted
Interventions
Elenestinib
Placebo
Prenatal InterventionPrenatal Behavioral Intervention to Prevent Maternal Cytomegalovirus (CMV) in Pregnancy
Sponsor:
University of Alabama at Birmingham
Location:
Code:
NCT04615715
Conditions
Maternal Cytomegalovirus Infections
Cytomegalovirus Congenital
Eligibility Criteria
Sex: Female
Age: 14 - 39
Healthy Volunteers: Accepted
Interventions
CMV Risk-Reduction Intervention
Stress Reduction Messaging
Observational StudyMicroRNA Correlates of Childhood Maltreatment and Suicidality
Sponsor:
University of Alabama at Birmingham
Location:
Code:
NCT04923685
Conditions
Major Depressive Disorder
Suicidal Ideation
Eligibility Criteria
Sex: All
Age: 18 - 60
Healthy Volunteers: Accepted
Interventions
Trier Social Stress Test
KRT-232 & TL-895KRT-232 in Combination With TL-895 for the Treatment of R/R MF and KRT-232 for the Treatment of JAKi Intolerant MF
Sponsor:
Kartos Therapeutics, Inc.
Location:
Code:
NCT04640532
Conditions
Myelofibrosis
Post-PV MF
Post-ET Myelofibrosis
Primary Myelofibrosis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
KRT-232
TL-895